Incretin-Based Therapies
Viewpoints on the way to consensus
- Michael. A. Nauck, MD1,
- Tina Vilsbøll, MD2,
- Baptist Gallwitz, MD3,
- Alan Garber, MD4 and
- Sten Madsbad, MD5
- 1Diabetes Center Bad Lauterberg, Bad Lauterberg im Harz, Germany;
- 2Department of Internal Medicine, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark;
- 3Department of Medicine IV, Eberhard-Karls University Tübingen, Tübingen, Germany;
- 4Division of Diabetes, Endocrinology & Metabolism, Baylor College of Medicine, Houston, Texas;
- 5Department of Endocrinology, Hvidovre University Hospital, University of Copenhagen, Copenhagen, Denmark.
- Corresponding author: Michael A. Nauck, m.nauck{at}diabeteszentrum.de.
Article Information
vol. 32 no. suppl 2 S223-S231
PubMed
Published By
Print ISSN
Online ISSN
History
- Published in print October 29, 2009.
Copyright & Usage
© 2009 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
Author Information
- Michael. A. Nauck, MD1,
- Tina Vilsbøll, MD2,
- Baptist Gallwitz, MD3,
- Alan Garber, MD4 and
- Sten Madsbad, MD5
- 1Diabetes Center Bad Lauterberg, Bad Lauterberg im Harz, Germany;
- 2Department of Internal Medicine, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark;
- 3Department of Medicine IV, Eberhard-Karls University Tübingen, Tübingen, Germany;
- 4Division of Diabetes, Endocrinology & Metabolism, Baylor College of Medicine, Houston, Texas;
- 5Department of Endocrinology, Hvidovre University Hospital, University of Copenhagen, Copenhagen, Denmark.
- Corresponding author: Michael A. Nauck, m.nauck{at}diabeteszentrum.de.